Table of Contents Author Guidelines Submit a Manuscript
International Journal of Nephrology
Volume 2016 (2016), Article ID 9185413, 8 pages
http://dx.doi.org/10.1155/2016/9185413
Clinical Study

Is Anticoagulation Discontinuation Achievable with Citrate Dialysate during HDF Sessions?

1AUB Santé, Saint-Malo Dialysis Unit, 1 rue de la Marne, 35400 Saint-Malo, France
2Rennes 1 University, CHU Rennes Department of Clinical Pharmacology, INSERM Pharmacoepidemiology Team CIC0203 BIOSIT, 35043 Rennes, France
3Hôpital de Saint-Malo, Medical Laboratory, 35400 Saint-Malo, France

Received 4 June 2016; Revised 29 August 2016; Accepted 15 September 2016

Academic Editor: Alessandro Amore

Copyright © 2016 Thibault Dolley-Hitze et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. N. Lai, K. Ho, R. C. K. Cheung et al., “Effect of low molecular weight heparin on bone metabolism and hyperlipidemia in patients on maintenance hemodialysis,” International Journal of Artificial Organs, vol. 24, no. 7, pp. 447–455, 2001. View at Google Scholar · View at Scopus
  2. C. M. Barbagallo, D. Noto, A. B. Cefalù et al., “Heparin induces an accumulation of atherogenic lipoproteins during hemodialysis in normolipidemic end-stage renal disease patients,” Hemodialysis International, vol. 19, no. 3, pp. 360–367, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. T. Petitclerc, R. Diab, F. Le Roy, L. Mercadal, and J. Hmida, “Acetate-free hemodialysis: what does it mean?” Nephrologie et Therapeutique, vol. 7, no. 2, pp. 92–98, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. L. Mercadal, J.-E. Franck, M. Metzger et al., “Improved survival associated with acetate-free haemodialysis in elderly: a registry-based study,” Nephrology Dialysis Transplantation, vol. 30, no. 9, pp. 1560–1568, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Molina Nuñez, R. de Alarcón, S. Roca et al., “Citrate versus acetate-based dialysate in on-line haemodiafiltration. A prospective cross-over study,” Blood Purification, vol. 39, pp. 181–187, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Ahmad, R. Callan, J. J. Cole, and C. R. Blagg, “Dialysate made from dry chemicals using citric acid increases dialysis dose,” American Journal of Kidney Diseases, vol. 35, no. 3, pp. 493–499, 2000. View at Publisher · View at Google Scholar · View at Scopus
  7. R. J. Kossmann, A. Gonzales, R. Callan, and S. Ahmad, “Increased efficiency of hemodialysis with citrate dialysate: a prospective controlled study,” Clinical Journal of the American Society of Nephrology, vol. 4, no. 9, pp. 1459–1464, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. L. Gabutti, N. Ferrari, G. Mombelli, F. Keller, and C. Marone, “The favorable effect of regional citrate anticoagulation on interleukin-1β release is dissociated from both coagulation and complement activation,” Journal of Nephrology, vol. 17, no. 6, pp. 819–825, 2004. View at Google Scholar · View at Scopus
  9. A. Dhondt, R. Vanholder, C. Tielemans et al., “Effect of regional citrate anticoagulation on leukopenia, complement activation, and expression of leukocyte surface molecules during hemodialysis with unmodified cellulose membranes,” Nephron, vol. 85, no. 4, pp. 334–342, 2000. View at Publisher · View at Google Scholar · View at Scopus
  10. V. Panichi, E. Fiaccadori, A. Rosati et al., “Post-dilution on line haemodiafiltration with citrate dialysate: first clinical experience in chronic dialysis patients,” The Scientific World Journal, vol. 2013, Article ID 703612, 7 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. L. Gabutti, B. Lucchini, C. Marone, L. Alberio, and M. Burnier, “Citrate- vs. acetate-based dialysate in bicarbonate haemodialysis: consequences on haemodynamics, coagulation, acid-base status, and electrolytes,” BMC Nephrology, vol. 10, no. 1, article 7, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Kuragano, A. Kida, M. Furuta et al., “Effects of acetate-free citrate-containing dialysate on metabolic acidosis, anemia, and malnutrition in hemodialysis patients,” Artificial Organs, vol. 36, no. 3, pp. 282–290, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Morabito, V. Pistolesi, L. Tritapepe, and E. Fiaccadori, “Regional citrate anticoagulation for RRTs in critically ill patients with AKI,” Clinical Journal of the American Society of Nephrology, vol. 9, no. 12, pp. 2173–2188, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Schneider, K. Thomas, L. Liefeldt et al., “Efficacy and safety of intermittent hemodialysis using citrate as anticoagulant: a prospective study,” Clinical Nephrology, vol. 68, no. 5, pp. 302–307, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. J. J. Sands, P. Kotanko, J. H. Segal et al., “Effects of citrate acid concentrate (Citrasate®) on heparin N requirements and hemodialysis adequacy: a multicenter, prospective noninferiority trial,” Blood Purification, vol. 33, no. 1–3, pp. 199–204, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. Y.-L. Cheng, A. W. Yu, K.-Y. Tsang et al., “Anticoagulation during haemodialysis using a citrate-enriched dialysate: a feasibility study,” Nephrology Dialysis Transplantation, vol. 26, no. 2, pp. 641–646, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. K. François, K. M. Wissing, R. Jacobs, D. Boone, K. Jacobs, and C. Tielemans, “Avoidance of systemic anticoagulation during intermittent haemodialysis with heparin-grafted polyacrilonitrile membrane and citrate-enriched dialysate: a retrospective cohort study,” BMC Nephrology, vol. 15, article 104, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Aniort, T. Petitclerc, and C. Créput, “Safe use of citric acid-based dialysate and heparin removal in postdilution online hemodiafiltration,” Blood Purification, vol. 34, no. 3-4, pp. 336–343, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. P. D. S. Ortiz, M. A. Ramón, R. Pérez-García et al., “Acute effect of citrate baths on post-dialysis alkalemia,” Nefrologia, vol. 35, no. 2, pp. 164–171, 2015. View at Publisher · View at Google Scholar · View at Scopus
  20. R. Šafránek, P. Moučka, J. Vávrová, V. Palička, L. Pavlíková, and S. D. Sulková, “Changes of serum calcium, magnesium and parathyroid hormone induced by hemodialysis with citrate-enriched dialysis solution,” Kidney and Blood Pressure Research, vol. 40, no. 1, pp. 13–21, 2016. View at Publisher · View at Google Scholar · View at Scopus
  21. G. Grundström, A. Christensson, M. Alquist, L.-G. Nilsson, and M. Segelmark, “Replacement of acetate with citrate in dialysis fluid: a randomized clinical trial of short term safety and fluid biocompatibility,” BMC Nephrology, vol. 14, article 216, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Schmitz, O. Loke, B. Fach et al., “Effects of citrate dialysate in chronic dialysis: a multicentre randomized crossover study,” Nephrology Dialysis Transplantation, vol. 31, no. 8, pp. 1327–1334, 2016. View at Publisher · View at Google Scholar
  23. D. J. Tai, K. Leung, P. Ravani, R. R. Quinn, N. Scott-Douglas, and J. M. MacRae, “The effect of citrate dialysate on intradialytic heparin dose in haemodialysis patients: study design of a randomised controlled trial,” BMC Nephrology, vol. 16, article 147, 2015. View at Publisher · View at Google Scholar